Featured in johnson & johnson
What the COVID-19 vaccine booster data still can’t tell us
Behind the FDA decisions, questions still remain.
FDA expert panel recommends all J&J vaccine recipients get a booster
The one-shot vaccine might have always been meant to be a two-dose regimen.
Mixing boosters, tuberculosis rising, and other COVID news you missed this week
Here's everything you need to know this week.
Everything you need to know about COVID booster shots
Whether boosters will be needed for the general population isn’t yet known.
What we know so far about J&J booster shots
New data from Johnson & Johnson shows promise, but the results haven't been reviewed yet by the CDC or FDA.
Breakthrough cases won’t stop vaccines from ending the pandemic
3 questions about how well COVID-19 vaccines work, answered.
The J&J vaccine may be less effective against the Delta variant than we hoped
A preliminary study shows that the J&J vaccine doesn't seem to produce as many antibodies in recipients as the mRNA options.
Why the FDA issued a new warning about the J&J vaccine
The benefits still overwhelmingly outweigh the risks, experts stress.
Why Belgium is limiting the Johnson & Johnson COVID vaccine to adults over 40
The European Union is reviewing a case of a deadly blood clot.
The US will send 20 million COVID-19 vaccines to countries in need
Here's what you need to know this week.